Race in a Bottle: The Story of BiDil and Racialized Medicine in a Post-Genomic Age

4.38 avg rating
( 8 ratings by Goodreads )
 
9780231162982: Race in a Bottle: The Story of BiDil and Racialized Medicine in a Post-Genomic Age

At a ceremony announcing the completion of the first draft of the human genome in 2000, President Bill Clinton declared, "I believe one of the great truths to emerge from this triumphant expedition inside the human genome is that in genetic terms, all human beings, regardless of race, are more than 99.9 percent the same." Yet despite this declaration of unity, biomedical research has focused increasingly on mapping that.1 percent of difference, particularly as it relates to race.

This trend is exemplified by the drug BiDil. Approved by the FDA in 2005 as the first drug with a race-specific indication on its label, BiDil was originally touted as a pathbreaking therapy to treat heart failure in black patients and help underserved populations. Upon closer examination, however, Jonathan Kahn reveals a far more complex story. At the most basic level, BiDil became racial through legal maneuvering and commercial pressure as much as through medical understandings of how the drug worked.

Using BiDil as a central case study, Kahn broadly examines the legal and commercial imperatives driving the expanding role of race in biomedicine, even as scientific advances in genomics could render the issue irrelevant. He surveys the distinct politics informing the use of race in medicine and the very real health disparities caused by racism and social injustice that are now being cast as a mere function of genetic difference. Calling for a more reasoned approach to using race in biomedical research and practice, Kahn asks readers to recognize that, just as genetics is a complex field requiring sensitivity and expertise, so too is race, particularly in the field of biomedicine.

"synopsis" may belong to another edition of this title.

Book Description:

Approved by the FDA in 2005, BiDil was originally touted as a pathbreaking therapy to treat heart failure in black patients and help underserved populations. Upon closer examination, Jonathan Kahn reveals BiDil became racial through legal maneuvering and commercial pressure as much as through medical understandings of how the drug worked. Using BiDil as a case study, Kahn broadly examines the distinct politics informing the use of race in medicine and the very real health disparities caused by racism and social injustice that are being cast as a function of genetic difference. Kahn shows that, just as genetics is a complex field requiring sensitivity and expertise, so too is race, particularly in the field of biomedicine.

About the Author:

Jonathan Kahn is professor of law at Hamline University School of Law. He holds a Ph.D. in United States history from Cornell University and a J.D. from the Boalt Hall School of Law, University of California, Berkeley. He is the author of Budgeting Democracy: State Building and Citizenship in America, 1897–1928.

"About this title" may belong to another edition of this title.

Top Search Results from the AbeBooks Marketplace

1.

Kahn, Jonathan
Published by Columbia Univ. Press, New York (2013)
ISBN 10: 0231162987 ISBN 13: 9780231162982
New Hardcover First Edition Quantity Available: 1
Seller:
Great Northern Books
(Minneapolis, MN, U.S.A.)
Rating
[?]

Book Description Columbia Univ. Press, New York, 2013. Hardcover. Book Condition: New. Dust Jacket Condition: new. First printing. "Using BiDil as a central case study, Kahn broadly examines the legal and commercial imperatives driving the expanding role of race in biomedicine." [from publisher] A review copy with publisher's material loosely laid in. Includes bibliographical references and index. Bookseller Inventory # 6929

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 18.00
Convert Currency

Add to Basket

Shipping: US$ 4.00
Within U.S.A.
Destination, Rates & Speeds

2.

Kahn, Jonathan
Published by Columbia University Press (2012)
ISBN 10: 0231162987 ISBN 13: 9780231162982
New Hardcover Quantity Available: 2
Seller:
Murray Media
(North Miami Beach, FL, U.S.A.)
Rating
[?]

Book Description Columbia University Press, 2012. Hardcover. Book Condition: New. Never used!. Bookseller Inventory # P110231162987

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 60.36
Convert Currency

Add to Basket

Shipping: US$ 1.99
Within U.S.A.
Destination, Rates & Speeds

3.

Kahn, Jonathan
Published by Columbia University Press
ISBN 10: 0231162987 ISBN 13: 9780231162982
New Hardcover Quantity Available: 1
Seller:
Cloud 9 Books
(Wellington, FL, U.S.A.)
Rating
[?]

Book Description Columbia University Press. Hardcover. Book Condition: New. 0231162987 New Condition. Bookseller Inventory # NEW7.0994620

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 59.99
Convert Currency

Add to Basket

Shipping: US$ 4.99
Within U.S.A.
Destination, Rates & Speeds

4.

Jonathan Kahn
Published by Columbia University Press (2013)
ISBN 10: 0231162987 ISBN 13: 9780231162982
New Quantity Available: > 20
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)
Rating
[?]

Book Description Columbia University Press, 2013. HRD. Book Condition: New. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Bookseller Inventory # WI-9780231162982

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 59.43
Convert Currency

Add to Basket

Shipping: US$ 11.88
From United Kingdom to U.S.A.
Destination, Rates & Speeds

5.

Jonathan Kahn
Published by Columbia University Press, United States (2012)
ISBN 10: 0231162987 ISBN 13: 9780231162982
New Hardcover Quantity Available: 10
Seller:
The Book Depository US
(London, United Kingdom)
Rating
[?]

Book Description Columbia University Press, United States, 2012. Hardback. Book Condition: New. Language: English . Brand New Book. At a ceremony announcing the completion of the first draft of the human genome in 2000, President Bill Clinton declared, I believe one of the great truths to emerge from this triumphant expedition inside the human genome is that in genetic terms, all human beings, regardless of race, are more than 99.9 percent the same. Yet despite this declaration of unity, biomedical research has focused increasingly on mapping that.1 percent of difference, particularly as it relates to race. This trend is exemplified by the drug BiDil. Approved by the FDA in 2005 as the first drug with a race-specific indication on its label, BiDil was originally touted as a pathbreaking therapy to treat heart failure in black patients and help underserved populations. Upon closer examination, however, Jonathan Kahn reveals a far more complex story. At the most basic level, BiDil became racial through legal maneuvering and commercial pressure as much as through medical understandings of how the drug worked. Using BiDil as a central case study, Kahn broadly examines the legal and commercial imperatives driving the expanding role of race in biomedicine, even as scientific advances in genomics could render the issue irrelevant. He surveys the distinct politics informing the use of race in medicine and the very real health disparities caused by racism and social injustice that are now being cast as a mere function of genetic difference. Calling for a more reasoned approach to using race in biomedical research and practice, Kahn asks readers to recognize that, just as genetics is a complex field requiring sensitivity and expertise, so too is race, particularly in the field of biomedicine. Bookseller Inventory # AAH9780231162982

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 75.85
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

6.

Jonathan Kahn
Published by Columbia University Press, United States (2012)
ISBN 10: 0231162987 ISBN 13: 9780231162982
New Hardcover Quantity Available: 10
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Columbia University Press, United States, 2012. Hardback. Book Condition: New. Language: English . Brand New Book. At a ceremony announcing the completion of the first draft of the human genome in 2000, President Bill Clinton declared, I believe one of the great truths to emerge from this triumphant expedition inside the human genome is that in genetic terms, all human beings, regardless of race, are more than 99.9 percent the same. Yet despite this declaration of unity, biomedical research has focused increasingly on mapping that.1 percent of difference, particularly as it relates to race.This trend is exemplified by the drug BiDil. Approved by the FDA in 2005 as the first drug with a race-specific indication on its label, BiDil was originally touted as a pathbreaking therapy to treat heart failure in black patients and help underserved populations. Upon closer examination, however, Jonathan Kahn reveals a far more complex story. At the most basic level, BiDil became racial through legal maneuvering and commercial pressure as much as through medical understandings of how the drug worked. Using BiDil as a central case study, Kahn broadly examines the legal and commercial imperatives driving the expanding role of race in biomedicine, even as scientific advances in genomics could render the issue irrelevant. He surveys the distinct politics informing the use of race in medicine and the very real health disparities caused by racism and social injustice that are now being cast as a mere function of genetic difference. Calling for a more reasoned approach to using race in biomedical research and practice, Kahn asks readers to recognize that, just as genetics is a complex field requiring sensitivity and expertise, so too is race, particularly in the field of biomedicine. Bookseller Inventory # AAH9780231162982

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 77.31
Convert Currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, Rates & Speeds

7.

Jonathan Kahn
Published by Columbia University Press (2012)
ISBN 10: 0231162987 ISBN 13: 9780231162982
New Hardcover Quantity Available: 1
Seller:
Irish Booksellers
(Rumford, ME, U.S.A.)
Rating
[?]

Book Description Columbia University Press, 2012. Hardcover. Book Condition: New. book. Bookseller Inventory # M0231162987

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 86.42
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

8.

Jonathan Kahn
Published by Columbia University Press 2013-01-04, New York (2013)
ISBN 10: 0231162987 ISBN 13: 9780231162982
New Hardcover Quantity Available: 5
Seller:
Blackwell's
(Oxford, OX, United Kingdom)
Rating
[?]

Book Description Columbia University Press 2013-01-04, New York, 2013. hardback. Book Condition: New. Bookseller Inventory # 9780231162982

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 81.01
Convert Currency

Add to Basket

Shipping: US$ 7.91
From United Kingdom to U.S.A.
Destination, Rates & Speeds

9.

Jonathan Kahn
ISBN 10: 0231162987 ISBN 13: 9780231162982
New Hardcover Quantity Available: 1
Seller:
Grand Eagle Retail
(Wilmington, DE, U.S.A.)
Rating
[?]

Book Description 2012. Hardcover. Book Condition: New. Hardcover. At a ceremony announcing the completion of the first draft of the human genome in 2000, President Bill Clinton declared, "I believe one of the great truths to emerge from this triumph.Shipping may be from multiple locations in the US or from the UK, depending on stock availability. 311 pages. 0.567. Bookseller Inventory # 9780231162982

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 97.54
Convert Currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, Rates & Speeds

10.

Jonathan Kahn
Published by Columbia University Press
ISBN 10: 0231162987 ISBN 13: 9780231162982
New Hardcover Quantity Available: > 20
Seller:
THE SAINT BOOKSTORE
(Southport, United Kingdom)
Rating
[?]

Book Description Columbia University Press. Hardcover. Book Condition: New. New copy - Usually dispatched within 2 working days. Bookseller Inventory # B9780231162982

More Information About This Seller | Ask Bookseller a Question

Buy New
US$ 88.70
Convert Currency

Add to Basket

Shipping: US$ 9.15
From United Kingdom to U.S.A.
Destination, Rates & Speeds

There are more copies of this book

View all search results for this book